This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

Contact Us

What can we help you find?

Top Searches

PROTAC

ADC

RNA

ADME

OLIGO

A Novel Validated LC-MS/MS Approach for Simultaneous Determination of Total Antibody and Conjugated Payload for DS-8201 in SD Rat Serum

  • Posters

  • August 08,2024

Posters Overview

Trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, comprises of an anti-HER2 antibody, a cleavable linker, and a topoisomerase I inhibitor payload, and an enzymatically cleavable peptide-based linker. DS-8201 addresses the limitations of previous-generation ADCs. To learn the DS-8201 actual effect on the disease, the conjugated payload and total antibody in the body should be monitored. Therefore, it is necessary to establish a method for both of them. UPLC-MS/MS is a sensitive platform for peptide and payload analysis. It can be used to detect them simultaneously.

A Novel Validated LC-MS/MS Approach for Simultaneous Determination of Total Antibody and Conjugated Payload for DS-8201 in SD Rat Serum

Complete the form to view and download this poster.

  • First name *
    * Please check the filled content
  • Last name *
    * Please check the filled content
  • Email address *
    * Please check the filled content
  • Phone number
  • Company *
    * Please enter a valid e-mail address
  • Department *
    * Please check the filled content
  • Country *
    * Please check the filled content
  • Position *
    * Please check the filled content
  • City *
    * Please check the filled content
  • Focus area (Service you are interested in)
  • I want to receive the latest news, insights, and communication from WuXi AppTec DMPK. I understand that I can unsubscribe at any time.

    I acknowledge and agree that WuXi AppTec DMPK may transfer my personal information across borders for the purpose of providing products and services through resources worldwide.

    By clicking submit below, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

    * Please agree to the Privacy Policy

Stay Connected

Keep up with the latest news and insights.

  • Email address*

    * Please check the filled content
  • First name*

    * Please check the filled content
  • Last name*

    * Please check the filled content
  • Company*

    * Please check the filled content

By clicking submit, you consent to WuXi AppTec DMPK collecting and processing the information you provide for our internal purposes, in accordance with our privacy policy.

* Please agree to the Privacy Policy

Thanks for signing up

Help us get to know you better! By customizing your email preferences, we can deliver curated content relevant to you.